# CED Regulatory Digest: Latest Cannabinoid Labeling Guidance Updates > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabinoid-labeling-guidance-updates-digest/ > **Published:** 2026-03-20T23:06:24-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T16:09:44-04:00 > **Clinical Summary:** Explore the latest cannabinoid labeling guidance updates impacting compliance and regulatory posture in this CED Regulatory Digest. --- Table of Contents - [CED Regulatory Digest, Since Last Digest, 14 items](#CED_Regulatory_Digest_Since_Last_Digest_14_items) - [FDA docket update on cannabinoid labeling guidance #9](#FDA_docket_update_on_cannabinoid_labeling_guidance_9) - [FDA docket update on cannabinoid labeling guidance #8](#FDA_docket_update_on_cannabinoid_labeling_guidance_8) - [FDA docket update on cannabinoid labeling guidance #7](#FDA_docket_update_on_cannabinoid_labeling_guidance_7) - [FDA docket update on cannabinoid labeling guidance #6](#FDA_docket_update_on_cannabinoid_labeling_guidance_6) - [FDA docket update on cannabinoid labeling guidance #19](#FDA_docket_update_on_cannabinoid_labeling_guidance_19) - [FDA docket update on cannabinoid labeling guidance #18](#FDA_docket_update_on_cannabinoid_labeling_guidance_18) - [FDA docket update on cannabinoid labeling guidance #17](#FDA_docket_update_on_cannabinoid_labeling_guidance_17) - [FDA docket update on cannabinoid labeling guidance #16](#FDA_docket_update_on_cannabinoid_labeling_guidance_16) - [FDA docket update on cannabinoid labeling guidance #15](#FDA_docket_update_on_cannabinoid_labeling_guidance_15) - [FDA docket update on cannabinoid labeling guidance #14](#FDA_docket_update_on_cannabinoid_labeling_guidance_14) - [FDA docket update on cannabinoid labeling guidance #13](#FDA_docket_update_on_cannabinoid_labeling_guidance_13) - [FDA docket update on cannabinoid labeling guidance #12](#FDA_docket_update_on_cannabinoid_labeling_guidance_12) - [FDA docket update on cannabinoid labeling guidance #11](#FDA_docket_update_on_cannabinoid_labeling_guidance_11) - [FDA docket update on cannabinoid labeling guidance #10](#FDA_docket_update_on_cannabinoid_labeling_guidance_10)[Related](#Related) ## CED Regulatory Digest, Since Last Digest, 14 items This digest groups recent regulatory items selected by the CED Merge Engine. ## FDA docket update on cannabinoid labeling guidance #9 A docket-related update affecting [cannabinoid labeling](https://cedclinic.com/product-transparency-cannabis-dispensaries-fort-myers/), compliance posture, and agency comment review. [Original source](https://www.regulations.gov/document/FDA-2026-1008) ## FDA docket update on cannabinoid labeling guidance #8 A docket-related update affecting [cannabinoid labeling](https://cedclinic.com/product-transparency-cannabis-dispensaries-fort-myers/), compliance posture, and agency comment review. [Original source](https://www.regulations.gov/document/FDA-2026-1007) ## FDA docket update on cannabinoid labeling guidance #7 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. [Original source](https://www.regulations.gov/document/FDA-2026-1006) ## FDA docket update on cannabinoid labeling guidance #6 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. [Original source](https://www.regulations.gov/document/FDA-2026-1005) ## FDA docket update on cannabinoid labeling guidance #19 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. [Original source](https://www.regulations.gov/document/FDA-2026-1018) ## FDA docket update on cannabinoid labeling guidance #18 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. [Original source](https://www.regulations.gov/document/FDA-2026-1017) ## FDA docket update on cannabinoid labeling guidance #17 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. [Original source](https://www.regulations.gov/document/FDA-2026-1016) ## FDA docket update on cannabinoid labeling guidance #16 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. [Original source](https://www.regulations.gov/document/FDA-2026-1015) ## FDA docket update on cannabinoid labeling guidance #15 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. [Original source](https://www.regulations.gov/document/FDA-2026-1014) ## FDA docket update on cannabinoid labeling guidance #14 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. [Original source](https://www.regulations.gov/document/FDA-2026-1013) ## FDA docket update on cannabinoid labeling guidance #13 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. [Original source](https://www.regulations.gov/document/FDA-2026-1012) ## FDA docket update on cannabinoid labeling guidance #12 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. [Original source](https://www.regulations.gov/document/FDA-2026-1011) ## FDA docket update on cannabinoid labeling guidance #11 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. [Original source](https://www.regulations.gov/document/FDA-2026-1010) ## FDA docket update on cannabinoid labeling guidance #10 A docket-related update affecting cannabinoid labeling, compliance posture, and agency comment review. [Original source](https://www.regulations.gov/document/FDA-2026-1009) {“@context”: “https://schema.org”, “@type”: “CollectionPage”, “name”: “CED Regulatory Digest, Since Last Digest, 14 items”, “about”: [“regulations.gov”]} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence CED Regulatory Digest, Since Last Digest, 1 items A focused update on the most recent single regulatory item affecting cannabinoid compliance and labeling. Read More [CED Regulatory Digest, Since Last Digest, 2 items](https://cedclinic.com/ced-regulatory-digest-since-last-digest-2-items/) Summary of two recent regulatory developments impacting [cannabinoid product labeling](https://cedclinic.com/unregulated-intoxicating-hemp-products-risks-safety/) and compliance. [Explore Updates](https://cedclinic.com/ced-regulatory-digest-since-last-digest-2-items/) [regulations.gov](https://cedclinic.com/untitled/) Access the primary source for federal [regulatory updates](https://cedclinic.com/medicinal-cannabis-clinical-updates-april-2026-roundup/) including cannabinoid labeling guidance and compliance dockets. [Visit Site](https://cedclinic.com/untitled/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=CED%20Regulatory%20Digest%3A%20Latest%20Cannabinoid%20Labeling%20Guidance%20Updates&url=https%3A%2F%2Fcedclinic.com%2Fcannabinoid-labeling-guidance-updates-digest%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcannabinoid-labeling-guidance-updates-digest%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=CED%20Regulatory%20Digest%3A%20Latest%20Cannabinoid%20Labeling%20Guidance%20Updates%20https%3A%2F%2Fcedclinic.com%2Fcannabinoid-labeling-guidance-updates-digest%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).